Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection

AIDS Research and Human Retroviruses

Volumn 17, Issue 18, 2001, Pages 1767-1778

  Burkhard, Mary Jo ^a   Mathiason, Candace K ^a   Bowdre, Todd ^a   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GAG PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CAT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; GENOTYPE; IMMUNE RESPONSE; INOCULATION; NONHUMAN; PRIORITY JOURNAL; SALIVA LEVEL; VAGINA MUCOSA; VAGINA SECRETION; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, GAG; GLYCOPROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; T-LYMPHOCYTES, CYTOTOXIC; VAGINA; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 0035703620     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220152741469     Document Type: Article

References (58)

1. Overview of the mucosal immune system
2. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues
3. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
4. Mucosal immunity, HIV transmission, and AIDS
5. Regional specialization in the mucosal immune system: What happens in the microcompartments?
6. High-level ability of secretory IgA to block HIV type 1 transcytosis: Contrasting secretoty IgA and IgG responses to gly-coprotein 160
7. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
8. HIV-1 antibody serum negativity with vaginal secretions positivity
9. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection
10. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
11. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
12. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
13. Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with control of acute HIV-1 infection in macaques
14. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys
15. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction
16. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats
17. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
18. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination
19. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women
20. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
21. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques
22. Mucosal phenotype of antiviral cytotoxic T lymphocytes in the vaginal mucosa of SIV-infected rhesus macaques
23. Detection of simian immunodeficiency virus Gag-specific CD8+ T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
24. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge
25. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission
26. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus
27. Vaginal and rectal infection of cats with feline immunodeficiency virus
28. Mucosally transmitted feline immunodeficiency virus induce a CD8+ antiviral response correlates with reduction of cell-associated virus
29. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: Nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum
30. Feline immunodeficiency virus clade C mucosal transmission and disease courses
31. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns
32. Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route
33. Flow cytometric analysis of T-lymphocyte subsets in cats
34. Characterization of a panel of monoclonal antibodies specific for subsets of feline leukocytes
35. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women
36. Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus
37. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide
38. Involvement of Gag- and Env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus
39. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24
40. Mammalian cell/vaccinia virus expression vectors with increased stability of retroviral sequence in Escherichia coli: Production of feline immunodeficiency virus envelope protein
41. Gender differences in HIV-1 diversity at time of infection
42. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties
43. SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque
44. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus
45. Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develops AIDS
46. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds
47. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity
48. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity
49. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
50. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
51. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques
52. Immunization of macaque monkeys with low- and high-dose regimens of SIV-mac results in different immune responses
53. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies
54. Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge
55. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers
56. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers
57. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers
58. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors